Boehringer Ingelheim Venture Fund
Corporate VC
Committed to advancing scientific innovation by investing in first-in-class, disease-modifying therapeutics across various modalities globally.
Seed
Early Stage
- Headquarters
- Ingelheim am Rhein, Germany
- Founded
- 2010
- AUM
- $350.0M
- Portfolio Company
- 1
- Last Investment
- Aug 2020
Investment Thesis
We invest in biotech and therapeutics ventures.
Portfolio1
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account